Phosphorylation of glucocorticoid receptor tau1c transactivation domain enhances binding to CREB binding protein (CBP) TAZ2

Biochemical and Biophysical Research Communications

Volumn 457, Issue 1, 2015, Pages 119-123

  Carruthers, Carl W ^a,b,c   Suh, Ji Ho ^a   Gustafsson, Jan Ake ^b   Webb, Paul ^a,b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b University of Houston   (United States)

^c NanoRacks LLC   (United States)

Author keywords

Coactivator; CREB binding protein; Gene expression; Glucocorticoid receptor; Phosphorylation; Protein biochemistry

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR TAU1C; TAZ2 PROTEIN; UNCLASSIFIED DRUG; CREBBP PROTEIN, HUMAN; PEPTIDE; PHOSPHOSERINE; PROTEIN BINDING;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; IN VITRO STUDY; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; CELL LINE; CREB-BINDING PROTEIN; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GLUCOCORTICOID; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTIONAL ACTIVATION;

EID: 84921684246     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.12.021     Document Type: Article

References (22)

1. N. Ismaili, M.J. Garabedian, Modulation of glucocorticoid receptor function via phosphorylation, Ann. N.Y. Acad. Sci. 1024 (2004) 86-101.
2. A.J. Galliher-Beckley, J.A. Cidlowski, Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease, IUBMB Life 61 (2009) 979-986.
3. I.M.E. Beck, W. Vanden Berghe, L. Vermeulen, K.R. Yamamoto, G. Haegeman, K. De Bosscher, Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases, Endocr. Rev. 30 (2009) 830-882.
4. A.E. Wallberg, A. Wright, J.A. Gustafsson, Chromatin-remodeling complexes involved in gene activation by the glucocorticoid receptor, Vitam. Horm. 60 (2000) 75-122.
5. I. Rogatsky, J.-C. Wang, M.K. Derynck, D.F. Nonaka, D.B. Khodabakhsh, C.M. Haqq, et al., Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor, Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13845-13850.
6. S.S. Simons, R. Kumar, Variable steroid receptor responses: intrinsically disordered AF1 is the key, Mol. Cell. Endocrinol. 376 (2013) 81-84.
7. J.C. Webster, C.M. Jewell, J.E. Bodwell, A. Munck, M. Sar, J.A. Cidlowski, Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein, J. Biol. Chem. 272 (1997) 9287-9293.
8. A.B. Hittelman, D. Burakov, J.A. Iñiguez-Lluhí, L.P. Freedman, M.J. Garabedian, Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins, EMBO J. 18 (1999) 5380-5388.
9. A. Wärnmark, J.A. Gustafsson, A.P. Wright, Architectural principles for the structure and function of the glucocorticoid receptor tau1 core activation domain, J. Biol. Chem. 275 (2000) 15014-15018.
10. T. Almlöf, A.E. Wallberg, J.A. Gustafsson, A.P. Wright, Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors, Biochemistry 37 (1998) 9586-9594.
11. T. Almlöf, J.A. Gustafsson, A.P. Wright, Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor, Mol. Cell. Biol. 17 (1997) 934-945.
12. A.E. Wallberg, K.E. Neely, J.A. Gustafsson, J.L. Workman, A.P. Wright, P.A. Grant, Histone acetyltransferase complexes can mediate transcriptional activation by the major glucocorticoid receptor activation domain, Mol. Cell. Biol. 19 (1999) 5952-5959.
13. A.E. Wallberg, E.M. Flinn, J.A. Gustafsson, A.P. Wright, Recruitment of chromatin remodelling factors during gene activation via the glucocorticoid receptor N-terminal domain, Biochem. Soc. Trans. 28 (2000) 410-414.
14. H. Feng, L.M.M. Jenkins, S.R. Durell, R. Hayashi, S.J. Mazur, S. Cherry, et al., Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation, Structure (London Engl.) 1993 (17) (2009) 202-210.
15. M. Arai, J.C. Ferreon, P.E. Wright, Quantitative analysis of multisite protein-ligand interactions by NMR: binding of intrinsically disordered p53 transactivation subdomains with the TAZ2 domain of CBP, J. Am. Chem. Soc. 134 (2012) 3792-3803.
16. J.M. Wojciak, M.A. Martinez-Yamout, H.J. Dyson, P.E. Wright, Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains, EMBO J. 28 (2009) 948-958.
17. J.C. Ferreon, M.A. Martinez-Yamout, H.J. Dyson, P.E. Wright, Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein, Proc. Natl. Acad. Sci. U.S.A. 106 (2009) 13260-13265.
18. S. Fan, Y.X. Ma, C. Wang, R.-Q. Yuan, Q. Meng, J.-A. Wang, et al., P300 modulates the BRCA1 inhibition of estrogen receptor activity, Cancer Res. 62 (2002) 141-151.
19. C. Mas, M. Lussier-Price, S. Soni, T. Morse, G. Arseneault, P. Di Lello, et al., Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF), Proc. Natl. Acad. Sci. U.S.A. 108 (2011) 10484-10489.
20. L.M.M. Jenkins, H. Yamaguchi, R. Hayashi, S. Cherry, J.E. Tropea, M. Miller, et al., Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation, Biochemistry 48 (2009) 1244-1255.
21. J.A. Iñiguez-Lluhí, D.Y. Lou, K.R. Yamamoto, Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N terminus, J. Biol. Chem. 272 (1997) 4149-4156.
22. M. Miller, Z. Dauter, S. Cherry, J.E. Tropea, A. Wlodawer, Structure of the Taz2 domain of p300: insights into ligand binding, Acta Crystallogr. D Biol. Crystallogr. 65 (2009) 1301-1308.